Data availability
The datasets generated during the study are available from the corresponding author on reasonable request.
References
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N (2015) Vitiligo. Lancet 386:74–84. https://doi.org/10.1016/S0140-6736(14)60763-7
Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164:4991–4995. https://doi.org/10.4049/jimmunol.164.10.4991
Meephansan J, Komine M, Tsuda H et al (2013) Expression of IL-33 in the epidermis: the mechanism of induction by IL-17. J Dermatol Sci 71:107–114. https://doi.org/10.1016/j.jdermsci.2013.04.014
Hyder LA, Gonzalez J, Harden JL et al (2013) TREM-1 as a potential therapeutic target in psoriasis. J Invest Dermatol 133:1742–1751. https://doi.org/10.1038/jid.2013.68
Miniati A, Weng Z, Zhang B et al (2014) Stimulated human melanocytes express and release interleukin-8, which is inhibited by luteolin: relevance to early vitiligo. Clin Exp Dermatol 39:54–57. https://doi.org/10.1111/ced.12164
Funding
Authors I.B.A., L.G.S.B. and I.A.G. have received research support from CAPES (Finance Code 001). Authors A.A.S.A. has received research support from CNPq (Finance Code 308673/2020-4).
Author information
Authors and Affiliations
Contributions
All authors contribute equally to this manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethics approval
This study was approved by the Ethics Committee of Federal University of Sergipe (CAAE: 71411617.1.0000.5546).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sandes, I.L.L., Almeida, I.B., Menezes-Silva, L. et al. Evaluation of serum levels of soluble triggering receptor expressed on myeloid cells-1 in patients with vitiligo using Luminex-based assay. Arch Dermatol Res 315, 2951–2954 (2023). https://doi.org/10.1007/s00403-023-02716-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02716-0